Dr. Ileana Arias, Principal Deputy  Director Center for Disease Controland Prevention (CDC) and Agency forToxic Substances...
Prescription Drug Overdoses:The Public Health Perspective               Ileana Arias, PhD               Principal Deputy D...
Learning Objectives•  Describe current prescription drug overdose trends•  Identify populations at greatest risk for overd...
CDCSaving lives. Protecting people. Saving money.•  CDC works 24/7 to save lives, protect people and   communities from he...
CDC Goal  Reduceabuse and overdose of opioids and other controlled prescription drugs while ensuring patients with pain a...
The Public Health Approach       to Prevention                                             Ensure                         ...
The Public Health Approach       to Prevention                                             Ensure                         ...
Motor Vehicle Traffic, Poisoning, and Drug                                Overdose Death Rates: United States, 1980-2009De...
Number of Drug Overdose Deaths Involving  Opioid Pain Relievers and other Drugs:         United States, 1999-2009         ...
Unintentional Drug Overdose Deaths                                                     United States, 1970-2009           ...
Drug Overdose Deaths per 100,000 People,        United States, 2004-2008
Public Health Impact of Opioid Pain Reliever Use        For every 1 overdose death there are                          9   ...
Economic Costs•  $72.5 Billion in healthcare costs•  Opioid abusers generate, on   average, annual direct health   care co...
The Public Health Approach       to Prevention                                             Ensure                         ...
Rates of Opioid Overdose Deaths and Sales,                 1999-2010        8        7        6        5                  ...
Drug overdose death rate 2008 andopioid pain reliever sales rate 2010                                       Kg of opioid p...
Populations at High Risk for Overdose•    “Doctor Shoppers”•    People on high daily dosages of opioid pain     relievers ...
The Public Health Approach       to Prevention                                             Ensure                         ...
Administration’s Rx Abuse Plan              Where Does CDC Fit In?•    Blueprint for Federal     government•    4 Focus Ar...
CDC Strategic Focus Areas    Enhance Prescription Drug Abuse Surveillance    Improve Clinical Practice    Inform Policy
CDC Policy Recommendations•    Maximize Prescription Drug     Monitoring Programs (PDMPs)•    Evaluate and Implement     P...
CDC Policy Recommendations•    Enforce policies aimed at reducing drug diversion,     abuse and overdose•    Leverage Insu...
Conclusions•    Overdose deaths have reached     epidemic levels in the United States•    A concerted public health and   ...
Thank Youwww.cdc.gov/HomeandRecreationalSafety/Poisoning
ReferencesSlide 7:NCHS Data Brief, December, 2011, updated with 2009 mortality dataSlide 8:CDC/NCHS, National Vital Statis...
ReferencesSlides 14 & 15:National Vital Statistics System, DEA Automation of Reports and Consolidated Orders   System (ARC...
Upcoming SlideShare
Loading in …5
×

Dr. Ileana Arias

1,481 views
1,261 views

Published on

Current Trends Keynote
National Rx Drug Abuse Summit 4-11-12

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,481
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
85
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Dr. Ileana Arias

  1. 1. Dr. Ileana Arias, Principal Deputy Director Center for Disease Controland Prevention (CDC) and Agency forToxic Substances and Disease Registry (ATSDR)
  2. 2. Prescription Drug Overdoses:The Public Health Perspective Ileana Arias, PhD Principal Deputy Director Centers for Disease Control and Prevention April 10-12, 2012 Walt Disney World Swan Resort
  3. 3. Learning Objectives•  Describe current prescription drug overdose trends•  Identify populations at greatest risk for overdose•  Understand CDC’s public health approach to preventing prescription drug overdose•  Describe CDC’s policy recommendations on prescription drug overdose
  4. 4. CDCSaving lives. Protecting people. Saving money.•  CDC works 24/7 to save lives, protect people and communities from health threats, and save money•  CDC puts science and prevention into action to make the healthy choice the easy choice•  CDC helps people live longer, healthier, more productive lives with lower health care costs
  5. 5. CDC Goal  Reduceabuse and overdose of opioids and other controlled prescription drugs while ensuring patients with pain are safely and effectively treated..
  6. 6. The Public Health Approach to Prevention Ensure Widespread Adoption Develop and Test Prevention Strategies Identify Risk and Protective FactorsDefine the Problem
  7. 7. The Public Health Approach to Prevention Ensure Widespread Adoption Develop and Test Prevention Strategies Identify Risk and Protective FactorsDefine the Problem
  8. 8. Motor Vehicle Traffic, Poisoning, and Drug Overdose Death Rates: United States, 1980-2009Deaths per 100,000 population Year
  9. 9. Number of Drug Overdose Deaths Involving Opioid Pain Relievers and other Drugs: United States, 1999-2009 Any opioid pain reliever Specified drug(s) other than opioid analgesic Only non-specified drug(s) Year
  10. 10. Unintentional Drug Overdose Deaths United States, 1970-2009 28,578 unintentional overdose deaths in 2009 10Death Rate per 100,000 Population 9 8 7 6 5 4 3 2 1 0 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09
  11. 11. Drug Overdose Deaths per 100,000 People, United States, 2004-2008
  12. 12. Public Health Impact of Opioid Pain Reliever Use For every 1 overdose death there are 9 30 118 795
  13. 13. Economic Costs•  $72.5 Billion in healthcare costs•  Opioid abusers generate, on average, annual direct health care costs 8.7 times higher than nonabusers
  14. 14. The Public Health Approach to Prevention Ensure Widespread Adoption Develop and Test Prevention Strategies Identify Risk and Protective FactorsDefine the Problem
  15. 15. Rates of Opioid Overdose Deaths and Sales, 1999-2010 8 7 6 5 Opioid Overdose Deaths/ Rate 4 100,000 Opioid Sales KG/10,000 3 2 1 0 99 00 01 02 03 04 05 06 07 08 09 10 Year
  16. 16. Drug overdose death rate 2008 andopioid pain reliever sales rate 2010 Kg of opioid pain relievers used per 10,000 Age-adjusted rate per 100,000
  17. 17. Populations at High Risk for Overdose•  “Doctor Shoppers”•  People on high daily dosages of opioid pain relievers and poly-drug abusers•  Low-income people and those living in rural areas•  Medicaid populations•  People with mental illness or history of substance abuse
  18. 18. The Public Health Approach to Prevention Ensure Widespread Adoption Develop and Test Prevention Strategies Identify Risk and Protective FactorsDefine the Problem
  19. 19. Administration’s Rx Abuse Plan Where Does CDC Fit In?•  Blueprint for Federal government•  4 Focus Areas •  Education •  Monitoring •  Disposal •  Enforcement•  CDC is focusing on areas that fit within our mission and complement other Federal agencies
  20. 20. CDC Strategic Focus Areas  Enhance Prescription Drug Abuse Surveillance  Improve Clinical Practice  Inform Policy
  21. 21. CDC Policy Recommendations•  Maximize Prescription Drug Monitoring Programs (PDMPs)•  Evaluate and Implement Patient Review and Restriction programs•  Improve Clinical Practice Through Health Care Provider Accountability
  22. 22. CDC Policy Recommendations•  Enforce policies aimed at reducing drug diversion, abuse and overdose•  Leverage Insurer & Pharmacy Benefit Manager (PBM) mechanisms•  Increase Access to Substance Abuse Treatment
  23. 23. Conclusions•  Overdose deaths have reached epidemic levels in the United States•  A concerted public health and public safety approach is required•  CDC is applying the public health model to this issue•  Success will come through collaboration with all stakeholders
  24. 24. Thank Youwww.cdc.gov/HomeandRecreationalSafety/Poisoning
  25. 25. ReferencesSlide 7:NCHS Data Brief, December, 2011, updated with 2009 mortality dataSlide 8:CDC/NCHS, National Vital Statistics System; and Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM. Drug poisoning deaths in the United States, 1980–2008. NCHS data brief, no 81. Hyattsville, MD: National Center for Health Statistics. 2011. http://www.cdc.gov/nchs/data/databriefs/db81.htmSlides 9 & 10:National Vital Statistics SystemSlide 11:SAMHSA National Survey on Drug Use and Health, SAMHSA Treatment Episode Data Set, SAMHSA Drug Abuse Warning NetworkSlide 12:1. Coalition Against Insurance Fraud. Prescription for peril: how insurance fraud finances theft and abuse of addictive prescription drugs. Washington, DC: Coalition Against Insurance Fraud; 2007.2. White AG, Birnbaum, HG, Mareva MN, et al. Direct Costs of Opioid Abuse in an Insured Population in the United States. J Manag Care Pharm. 11(6):469-479. 2005
  26. 26. ReferencesSlides 14 & 15:National Vital Statistics System, DEA Automation of Reports and Consolidated Orders System (ARCOS)Slide 16:1. White AG,; Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J of Managed Care 2009;15(12): 897-906.2. Green TC, Graub LE, Carver HW, Kinzly M, Heimer R. Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007. Drug and Alcohol Dependence 2011;115:221-8.3. Paulozzi et al. A history of being prescribed controlled substances and risk of drug overdose death. Pain Medicine. 2012; 13(1):87-954. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613– 20.5. CDC. Overdose deaths involving prescription opioids among Medicaid enrollees- Washington, 2004-2007.MMWR. 2010;59;705-9.6. Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305(13):1315–21.

×